相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。tAnGo: A randomized phase III trial of gemcitabine (gem) in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy (CT) for women with early-stage breast cancer (EBC)
C. J. Poole et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies
D. S. M. Chan et al.
ANNALS OF ONCOLOGY (2014)
Replication of Genetic Polymorphisms Reported to Be Associated with Taxane-Related Sensory Neuropathy in Patients with Early Breast Cancer Treated with Paclitaxel
Jean E. Abraham et al.
CLINICAL CANCER RESEARCH (2014)
Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo): an open-label, 2x2 factorial randomised phase 3 trial
Helena M. Earl et al.
LANCET ONCOLOGY (2014)
Presence of chemotherapy-induced toxicity predicts improved survival in patients with localised extremity osteosarcoma treated with doxorubicin and cisplatin: A report from the European Osteosarcoma Intergroup
Anne McTiernan et al.
EUROPEAN JOURNAL OF CANCER (2012)
Linking Toxicity to the Target
Stephen K. Chia et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Neuropathy Is Not Associated With Clinical Outcomes in Patients Receiving Adjuvant Taxane-Containing Therapy for Operable Breast Cancer
Bryan P. Schneider et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Carboplatin-paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer
C. K. Lee et al.
BRITISH JOURNAL OF CANCER (2011)
Meta-analysis of neutropenia or leukopenia as a prognostic factor in patients with malignant disease undergoing chemotherapy
Kohei Shitara et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
A randomized study of individually tailored toxicity-based dosage of fluorouracil-epirubicin-cyclophosphamide chemotherapy (FEC) for early breast cancer
H. Lindman et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Obesity and Breast Cancer Prognosis: Weight of the Evidence
Frank A. Sinicrope et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
Brian I. Rini et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Paclitaxel-Related Peripheral Neuropathy Associated with Improved Outcome of Patients with Early Stage HER2+ Breast Cancer Who Did Not Receive Trastuzumab in the N9831 Clinical Trial.
A. Moreno-Aspitia et al.
CANCER RESEARCH (2010)
Dose-Dense Chemotherapy in Nonmetastatic Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Luisa Bonilla et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth
A. McGarry Houghton et al.
NATURE MEDICINE (2010)
Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes
Marcin Kowanetz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Variability of Patterns of Fatigue and Quality of Life Over Time Based on Different Breast Cancer Adjuvant Chemotherapy Regimens
Ann M. Berger et al.
ONCOLOGY NURSING FORUM (2009)
The Symptom Cluster of Fatigue, Pain, Anxiety, and Depression and the Effect on the Quality of Life of Women Receiving Treatment for Breast Cancer: A Multicenter Study
Winnie K. W. So et al.
ONCOLOGY NURSING FORUM (2009)
NEAT: National Epirubicin Adjuvant Trial - toxicity, delivered dose intensity and quality of life
H. M. Earl et al.
BRITISH JOURNAL OF CANCER (2008)
Chemotherapy-related myelosuppression as a marker of survival in epithelial ovarian cancer patients
Rodney P. Rocconi et al.
GYNECOLOGIC ONCOLOGY (2008)
Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer
Christopher J. Poole et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis
Hiroaki Nozawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials
M Di Maio et al.
LANCET ONCOLOGY (2005)
Dose density by any other name - In Reply
ML Citron et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Moderate neutropenia with adjuvant CMF confers improved survival in early breast cancer
DA Cameron et al.
BRITISH JOURNAL OF CANCER (2003)
Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: First report of intergroup trial C9741/cancer and leukemia group B trial 9741
ML Citron et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer
IC Henderson et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer:: a randomised trial
J Bergh et al.
LANCET (2000)
分享论文
